877 related articles for article (PubMed ID: 25132759)
1. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
Shin VY; Chu KM
World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as potential biomarkers for gastric cancer.
Liu HS; Xiao HS
World J Gastroenterol; 2014 Sep; 20(34):12007-17. PubMed ID: 25232237
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNAs in gastric cancer.
Ishiguro H; Kimura M; Takeyama H
World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
[TBL] [Abstract][Full Text] [Related]
6. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
Chen Z; Saad R; Jia P; Peng D; Zhu S; Washington MK; Zhao Z; Xu Z; El-Rifai W
Cancer; 2013 Jun; 119(11):1985-93. PubMed ID: 23456798
[TBL] [Abstract][Full Text] [Related]
7. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets.
Wu X; Shen J; Xiao Z; Li J; Zhao Y; Zhao Q; Cho CH; Li M
Biochem Pharmacol; 2019 May; 163():425-439. PubMed ID: 30857828
[TBL] [Abstract][Full Text] [Related]
8. miRNA signature associated with outcome of gastric cancer patients following chemotherapy.
Kim CH; Kim HK; Rettig RL; Kim J; Lee ET; Aprelikova O; Choi IJ; Munroe DJ; Green JE
BMC Med Genomics; 2011 Nov; 4():79. PubMed ID: 22112324
[TBL] [Abstract][Full Text] [Related]
9. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
11. Integrative network analysis reveals active microRNAs and their functions in gastric cancer.
Tseng CW; Lin CC; Chen CN; Huang HC; Juan HF
BMC Syst Biol; 2011 Jun; 5():99. PubMed ID: 21703006
[TBL] [Abstract][Full Text] [Related]
12. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.
Zhang X; Peng Y; Jin Z; Huang W; Cheng Y; Liu Y; Feng X; Yang M; Huang Y; Zhao Z; Wang L; Wei Y; Fan X; Zheng D; Meltzer SJ
Oncotarget; 2015 Oct; 6(32):32878-89. PubMed ID: 26460735
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
14. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.
Wu HH; Lin WC; Tsai KW
Expert Rev Mol Med; 2014 Jan; 16():e1. PubMed ID: 24456939
[TBL] [Abstract][Full Text] [Related]
15. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p.
Su Y; Ni Z; Wang G; Cui J; Wei C; Wang J; Yang Q; Xu Y; Li F
Int Immunopharmacol; 2012 Aug; 13(4):468-75. PubMed ID: 22683180
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between the expression level of miR-29c and biological behavior of gastric cancer].
Ma XQ; Wang LP; Luo QC; Cai JC
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):325-30. PubMed ID: 24054006
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of MicroRNA Deregulation and MicroRNA Targets in Gastric Cancer.
Irmak-Yazicioglu MB
Oncol Res Treat; 2016; 39(3):136-9. PubMed ID: 27031864
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNA in gastric malignancy.
Nishizawa T; Suzuki H
Int J Mol Sci; 2013 Apr; 14(5):9487-96. PubMed ID: 23629677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
